Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.48 |
| ▸ | RAD52 | P43351 | 2/20 | 0.48 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.45 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9691972 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10933953 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10932296 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL61125 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL6236479 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10937742 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL60618 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL10975956 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL16604562 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 | |
| SCHEMBL61327 | 1.00 | HTT (0.60) | HTTDNM1KMT2AHSP90AA1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 871 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250264646-A1 | PHOTOCHROMIC ELEMENT CONTAINING SURFACTANT AND MANUFACTURING METHOD FOR THE SAME | KOREA UNIVERSITY OF TECHNOLOGY AND EDUCATION INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2025-08-21 | — | — | US | claimed |
| US-20250259801-A1 | WIDE VOLTAGE WINDOW AQUEOUS ELECTROLYTE SOLUTION FOR FORMING SEI FILM BASED ON PHYSICAL PROCESS, AND PREPARATION METHOD AND USE THEREOF | ZHEJIANG UNIVERSITY | 2025-08-14 | — | — | US | claimed |
| US-20240426841-A1 | KIT OF KL-6 PROTEIN ON EXOSOMES FOR AUXILIARY DIAGNOSIS OF INTERSTITIAL LUNG DISEASE AND USE THEREOF | Guangzhou Institute of respiratory health (Guangzhou Institute of respiratory diseases) (CN) | 2024-12-26 | — | — | US | claimed |
| WO-2024144002-A1 | PHOTOCHROMIC DEVICE CONTAINING SURFACTANT AND METHOD FOR MANUFACTURING SAME | 한국기술교육대학교 산학협력단 | 2024-07-04 | — | — | WO | claimed |
| WO-2024136320-A1 | COMPOSITION FOR SINGLE-CELL PROTEOMICS ANALYSIS, SAMPLE TREATMENT METHOD USING SAME, AND METHOD FOR UNIFYING LABELING OF ULTRA-SMALL AMOUNTS OF PEPTIDES | 재단법인대구경북과학기술원 | 2024-06-27 | — | — | WO | claimed |
| US-11656159-B2 | Composition for preparing biological material having excellent light transmissivity and use of composition | RIKEN (JP) | 2023-05-23 | — | — | US | claimed |
| EP-4072686-A1 | ORAL CARE COMPOSITION WITH N-ACETYL AMINO ACID COMPONENTS FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-10-19 | — | — | EP | claimed |
| EP-4034077-A1 | ORAL CARE COMPOSITION WITH AMMONIUM ALKYL SULFONATE OR CARBONATE COMPONENTS FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-08-03 | — | — | EP | claimed |
| US-11335513-B2 | Passivation of defects in perovskite materials for improved solar cell efficiency and stability | NUTECH VENTURES (US) | 2022-05-17 | — | — | US | claimed |
| US-11313863-B2 | Measurement of glycoprotein | ARKRAY, INC. (JP) | 2022-04-26 | — | — | US | claimed |
| WO-2005111608-A2 | TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY TEST REAGENTS AND METHODS USING THEM | IDEXX LABORATORIES, INC. (US) | 2005-11-24 | — | — | WO | claimed |
| US-20050239139-A1 | Transmissible spongiform encephalopathy test reagents and methods | IDEXX LABORATORIES, INC. (US) | 2005-10-27 | — | — | US | claimed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| US-20040259162-A1 | Solid phase cell lysis and capture platform | SIGMA-ALDRICH CO. | 2004-12-23 | — | — | US | claimed |
| WO-2004099384-A2 | SOLID PHASE CELL LYSIS AND CAPTURE PLATFORM | SIGMA-ALDRICH CO. (US) | 2004-11-18 | — | — | WO | claimed |
| WO-2004086945-A2 | PAPANICOLAU STAINING PROCESS | CYTYC CORPORATION (US) | 2004-10-14 | — | — | WO | claimed |
| US-20040191854-A1 | Papanicolau staining process | CYTYC CORPORATION | 2004-09-30 | — | — | US | claimed |
| US-5676931-A | DRUG DELIVERY | ABBOTT LABORATORIES (US) | 1997-10-14 | — | — | US | claimed |
| EP-0731688-A1 | AEROSOL DRUG FORMULATIONS FOR USE WITH NON-CFC PROPELLANTS | Abbott Laboratories (US) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015151-A1 | AEROSOL DRUG FORMULATIONS FOR USE WITH NON-CFC PROPELLANTS | ABBOTT LABORATORIES (US) | 1995-06-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11313863-B2 | Measurement of glycoprotein | HBG1, HBG2, HBB | HTT 1488/4885DNM1 4736/4885KMT2A 3253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.